The 12 closest competitors and alternatives to Object Pharma among drug discovery companies — ranked by similarity to what Object Pharma actually does, not by market-cap band.
Subscribe to see Object Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Object Pharma is a drug discovery company headquartered in United States. Its most recent funding round, Seed, raised $5M in May 2020. Xcout tracks 8 named people at Object Pharma, including Kenton Abel (CEO).
2 more named people on record for Object Pharma, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Object Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar drug discovery company
Aneira Pharma, Inc. is a privately held pharmaceutical company founded in 2008 with its headquarters in San Diego, California.
Similar drug discovery company
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Similar drug discovery company
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Similar drug discovery company
BRC Therapeutics is a pharmaceutical company headquartered in Castroville, California. The company focuses on developing proprietary cannabinoid therapeutics and innovative treatments to provide relief from pain and neurological conditions.
Similar drug discovery company
Enlaza Therapeutics, Inc. is a biotechnology enterprise headquartered in California, United States. The company designs and develops next-generation covalent biologic therapeutics targeting serious diseases. It utilizes specialized proprietary discovery platforms to advance precision medicine applications.
Similar drug discovery company
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Similar drug discovery company
Kinoxis Therapeutics Pty Ltd is an Australian-based, clinical-stage biotechnology company that develops first-in-class therapeutics targeting ALOX15 to address central nervous system (CNS) diseases.
Medtech
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Drug Delivery
OptiNose, Inc. is a specialty pharmaceutical company founded in 2010 and headquartered in Yardley, Pennsylvania, focusing on treatments in its designated drug industry.
Biopharmaceuticals
CytoDel, Inc. is a biopharmaceutical firm that produces recombinant botulinum neurotoxin derivatives and utilizes neurotoxins as molecular vehicles for intraneuronal drug delivery.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Object Pharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →